Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06254677 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Western Sydney Kidney Injury Biopsy Study

Study acronym: WESTKiD
StatusNot Yet Recruiting
PhaseNot specified
Started2024-05-01
View on ClinicalTrials.gov ↗

Amendment history

2024-04-22
Study Status v2
Start date2024-03-01→2024-05-01
2024-02-24
Study Status, Sponsor/Collaborators, Study Description, Outcome Measures v1
Secondary endpointsdetails revised at 8 of 8 entries
Study description+30 characters
[...] (Western Sydney Local Health District, WSLHD) Primary aim: Wethe investigators aim to derive a clinically validated scoring system for acu [...] of kidney biopsies performed to evaluate the cause of AKI. WeThe investigators will also be requesting waiver of consent for access to his [...]
2024-02-03
Original filing
The investigators aim to develop a clinically validated, histological acute tubular injury (ATI) scoring system to help improve diagnostic precision and predict clinical outcomes following ATI. To use an unbiased, data-driven approach, correlating pathological features (including digital pathology), key signatures using spatial technologies (transcriptomics or proteinomics) with relevant clinical outcomes. Spatial technologies (including spatial transcriptomics and spatial proteinomics) allow the use of 'precision pathology' to study the critical link between molecular characteristics to histological structure.
Trial Details
NCT Number NCT06254677
Lead Sponsor Western Sydney Local Health District
Conditions Kidney Injury
Enrollment 1,000 participants
Start Date 2024-05-01
Primary Completion 2035-01-01 (estimated)
Study Completion 2040-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-24